TITLE

Clopidogrel before percutaneous coronary intervention reduced cardiovascular outcome in ST-elevation myocardial infarction

PUB. DATE
March 2006
SOURCE
ACP Journal Club;Mar/Apr2006, Vol. 144 Issue 2, p29
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports that clopidogrel pretreatment before percutaneous coronary intervention (PCI) reduced cardiovascular outcome in ST-elevation myocardial infarction (MI). Patients in the clopidogrel group had lower rates of the composite endpoint from PCI to 30 days after randomization, recurrent MI or stroke before PCI and the composite endpoint from randomization to 30 days than placebo-group patients.
ACCESSION #
20297578

 

Related Articles

  • Evaluation of high dose atorvastatin therapy 24 hours before elective percutaneous coronary intervention on peri-PCI myocardial infarction. Rahmani, Reza; Nafasi, Latifeh; Salary, Arsalan; Meisami, Alipasha; Abdollahi, Alireza // Tehran University Medical Journal;Feb2013, Vol. 70 Issue 11, p717 

    Background: Percutaneous coronary intervention (PCI) may been associated with higher risk of cardiac events during this procedure. The goal of this study was to compare high dose atorvastatin therapy with low dose atorvastatin therapy 24 hours before PCI to a reduction in Peri- percutaneous...

  • Guidelines-based treatments benefit elderly with MI.  // PharmacoEconomics & Outcomes News;6/13/2009, Issue 580, p6 

    The article discusses research being done on the use of guidelines-recommended treatments in the clinical management of myocardial infarction (MI) in elderly patients. It references a study by F. Schiele and colleagues, published in the April 2009 issue of the "European Heart Journal." The study...

  • Health and Economic Benefits of Increased Beta-Blocker Use Following Myocardial Infarction. Phillips, Kathryn A.; Shilipak, Michael G.; Coxson, Pam; Heidenreich, Paul A.; Hunink, M. G. Myriam; Goldman, Paula A.; Williams, Lawrence W.; Weinstein, Milton C.; Goldman, Lee // JAMA: Journal of the American Medical Association;12/6/2000, Vol. 284 Issue 21, p2748 

    Reports on a study of the potential health and economic impact of increased use of beta-blockers in patients who have had myocardial infarction. Design; Setting; Main outcome measures; Results; Conclusion that increased use of beta-blockers after myocardial infarction could lead to gains in...

  • Focus on reteplase. Chow, Moses S.S. // Formulary;Jan1997, Vol. 32 Issue 1, p37 

    Provides information about reteplase, a third-generation thrombolytic agent for the treatment of acute myocardial infarction. Chemistry; Pharmacology; Pharmacokinetics; Clinical trials; Adverse effects and precautions; Drug and laboratory test interaction; Dosage and administration. INSET:...

  • Efficacy and Safety of Low-Molecular-Weight Heparins As An Adjunct to Thrombolysis in Acute ST-Elevation Myocardial Infarction. Rubboli, Andrea // Current Cardiology Reviews;2008, Vol. 4 Issue 1, p63 

    A 48-hour course of intravenous unfractionated heparin (UFH) is the standard of treatment in conjunction with fibrin-specific thrombolysis in ST-elevation myocardial infarction (STEMI). In recent trials, the efficacy and safety of inhospital administration of subcutaneous low-molecular-weight...

  • Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: Perspectives on Combination Therapy. Villareal, Rollo P.; Ferguson, James J.; Wilson, James M.; Kim, Paul // Texas Heart Institute Journal;2001, Vol. 28 Issue 4, p276 

    Examines clinical data on the combination therapies for unstable angina and non-ST-segment elevation, myocardial infarction. Use of aspirin as part of routine therapy for angina; Information on unfractioned heparin; Benefits of using the combination of aspirin and heparin.

  • Long-Term Effects of a Multimodal Behavioral Intervention on Myocardial Perfusion—a Randomized Controlled Trial. Albus, Christian; Theissen, Peter; Hellmich, Martin; Griebenow, Reinhard; Wilhelm, Beate; Aslim, Demet; Schicha, Harald; Köhle, Karl // International Journal of Behavioral Medicine;Sep2009, Vol. 16 Issue 3, p219 

    Recent advances in drug therapy question as to the additional impact behavioral interventions may have on the prognosis of patients with clinically stable coronary heart disease (CHD). The aim of the study was to evaluate the effects of a multimodal, behavioral intervention on myocardial...

  • Early Invasive vs Conservative Treatment Strategies in Women and Men With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction. O'Donoghue, Michelle; Boden, William E.; Braunwald, Eugene; Cannon, Christopher P.; Clayton, Tim C.; de Winter, Robbert J.; Fox, Keith A. A.; Lagerqvist, Bo; McCullough, Peter A.; Murphy, Sabina A.; Spacek, Rudolf; Swahn, Eva; Wallentin, Lars; Windhausen, Fons; Sabatine, Marc S. // JAMA: Journal of the American Medical Association;7/2/2008, Vol. 300 Issue 1, p71 

    The article presents a meta-analysis of randomized trials comparing the effects and outcomes of an invasive versus a conservative strategy in the treatment of male and female patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS). The criteria for data source searching, study...

  • Personal View. Ross, Alistair // British Medical Journal (Clinical Research Edition);11/7/1987, Vol. 295 Issue 6607, p1204 

    Relates experiences on the occurrence of mild coronary thrombosis in Great Britain. Use of thrombolytic agent for the treatment of mild coronary thrombosis; Installment of electrocardiography; Importance of a medical consultation in the occurrence of vague chest pains and dyspepsia.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics